1 Min Read
July 5 (Reuters) - Sanofi Sa
* Saskatchewan has added Lemtrada to province’s MS drugs program for eligible people living with relapsing-remitting multiple sclerosis Source text for Eikon: Further company coverage: )
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.